SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : FDA THRESHOLD: LOWER-RISK BIOTECH INVESTING
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Arthur Radley who wrote (67)12/9/2001 11:59:51 PM
From: Edscharp  Read Replies (1) of 75
 
Tex,

Thanks for the tip on BTRN, but I'm not so sure I agree with you.

First of all BTRN is in P2 trials for psoriasis. After my hard learned lessons with Xoma and a few other biotechs I've learned that NOBODY can know what the outcome of these trials. I don't believe that the average mortal can know when "somethings up" with these biotechs anymore. Even if the trials are a success the FDA could find a technical fault with the trial. This is exactly what happened to Aviron. Their trials proved that their Flumist vaccine works. No one questions this, but the FDA was unhappy about the fact that they used live viruses...so, well you can guess, they want more trials from Aviron.

Also, BTRN's chart is amazingly similar to a number of other biotechs. I offer this chart for you to peruse.

siliconinvestor.com

All of the above biotechs began to move in mid to late September and have shown very impressive chart gains since then.

I am going to stick with companies who have at least one potential blockbuster drug in P3 trials or a company that offers a unique technological platform for drug creation. The downside is the same as the BTRN's of the world, but the upside will be much more impressive.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News